Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy

Acta Neurol Scand. 1997 Oct;96(4):260-1. doi: 10.1111/j.1600-0404.1997.tb00280.x.

Abstract

Introduction: We describe bilateral optic neuropathy in a patient affected by ovarian carcinoma treated with cis-platin 160 mg/m2 and carboplatin, 640 mg/m2. The patient was followed for 1 year, when recovery appeared. The few previous descriptions of CDDP optic nerve toxicity did not report recovery.

Methods: Computerized visual field, visual evoked potentials, pattern electroretinograms, full field flash electroretinograms were recorded during follow-up.

Results: Optic neuritis appeared 13 weeks after cis-platin discontinuation, with right eye central scotoma; 2 days later the patient became bilaterally blind. Visual evoked potentials were initially absent, reappeared, with delayed latencies to left eye stimuli at 6 months, in both eyes at 9 months. At 1 year delayed VEPs were recorded with right eye stimuli, normal VEPs were recorded for left eye.

Conclusion: Cis-platin can induce delayed optic neuritis, that can recover in 1 year.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Carboplatin / administration & dosage
  • Carboplatin / adverse effects*
  • Chemotherapy, Adjuvant
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects*
  • Cystadenocarcinoma, Papillary / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Evoked Potentials, Visual / drug effects*
  • Evoked Potentials, Visual / physiology
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Optic Nerve / drug effects
  • Optic Nerve / physiopathology
  • Optic Neuritis / chemically induced*
  • Optic Neuritis / physiopathology
  • Ovarian Neoplasms / drug therapy*
  • Remission, Spontaneous
  • Substance Withdrawal Syndrome / diagnosis
  • Substance Withdrawal Syndrome / physiopathology
  • Visual Acuity / drug effects
  • Visual Acuity / physiology

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Cisplatin